Novel Therapeutic Milestone in the Treatment of Alzheimer’s Disease: Dawn of a New Era? A GameOn! Challenge

Released On
April 30, 2022

Expires On
April 29, 2023

Media Type
Internet

Completion Time
30 minutes

Specialty
Neurology, Family Medicine

Topic(s)
Alzheimer's

Scroll to the Bottom of this Information to Begin this Course

This continuing medical education activity is provided by Vindico Medical Education.

 

This activity is supported by an educational grant from Biogen.

Credit Available

  • Physicians — maximum of 0.5 AMA PRA Category 1 Credit(s)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

The intended audience for this activity is neurologists, family medicine physicians, internists, and other health care professionals involved in the management of patients with Alzheimer’s disease.

Statement of Need/Program Overview

This activity will cover the pathophysiology of Alzheimer’s disease and the importance of early diagnosis, as well as the clinical evidence supporting the use of conventional and recently approved therapies.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Assess the pathophysiology and rationale for the early diagnosis of Alzheimer’s disease (AD).
  • Examine the clinical evidence regarding conventional, recently approved, and emerging therapies for the treatment of patients with AD including impact on future treatment paradigms.

Faculty

FACULTY_NAME

Sharon Cohen, MD, FRCPC

Medical Director and Site Principal Investigator
Toronto Memory Program
Toronto, Ontario Canada

FACULTY_NAME

Raymond Scott Turner, PhD, MD, FAAN, FANA

Professor of Neurology
Director of the Memory Disorders Program
Georgetown University
Washington, DC

Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation Statement

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

ABIM MOC Accreditation Statement

Successful completion of this CME activity enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants who opt-in will earn MOC points equivalent to the amount of CME credits claimed for the activity.

Disclosures of Conflicts of Interest

Vindico Medical Education adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Faculty report the following relevant financial relationship(s):

Sharon Cohen, MD, FRCPC
  • Consultant: Alnylam, Biogen, Cassava, Cogstate, Eisai, INmune, Lilly, Novo Nordisk, ProMIS Neurosciences, Roche
  • Independent Research Contractor: AgeneBio, Alector, Alnylam, Anavex, Biogen, Cassava, Eisai, Green Valley, Janssen, Lilly, Novo Nordisk, Roche, UCB, Vielight
Raymond Scott Turner, PhD, MD, FAAN, FANA
  • Consultant: Jupiter Neuroscience, Re:Cognition Health
  • Independent Research Contractor (paid to institution): Biogen, Eisai, Genentech, Lilly, Novartis, Roche, Vaccinex
  • Individual Stocks and Stock Options: Jupiter Neuroscience

Reviewer reports the following relevant financial relationship(s):

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP, has no relevant financial relationships to disclose.

Vindico Medical Education Staff reports the following relevant financial relationship(s): No relevant financial relationships to disclose.

Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit. participants must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Unlabeled and Investigation Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Contact Information

For CME questions please contact: CME@VindicoCME.com